Member Info for Chelsea11

Matt, I believe Vulpes & Redmile (and others) may just be a tad interested.

SP back to starting with a 2?

More of a When than an If, imo.

Patience will very likely be rewarded, with all the rationale there in the RNS newsflow.

Well Crumbs, your post today was timed too late to be a lucky charm for news at 07:00 today but in plenty of time for an intraday, or tomorrow.

Still very early in H2 :-)

C7 - very good news for you Mister!

KTBFFH.

PS: It was me who mentioned the lack of recent posts by Crumbs. Hope nothing sinister there as enjoyed his/her posts. Back soon I hope.

Crackinblocker also highly recommended

AB. Maybe some see some comments as no more than banter rather than “suffocation” or “assassination”. However I wouldn’t know, as I’m not them.

AB, you’re asking me how I justify others actions / posts.

Not something I can, or want, to do.

Per clear note below. Personal perspective only on investment in an AIM Bio.

Personally, I believe anyone who invests any amount of money in an AIM biotech without full understanding that they might lose every penny, regardless of what anyone else might tell, or simply indicate to them, is a bit doltish. Has to be eyes wide open and full personal accountability in my view.

Please note, an entirely neutral & personal perspective, not aimed at any individual on the BB!

Diggle Wiggle & Redmile Shuffle.

Currently climbing the R&B Charts.

I’m hoping for a little more than pleasantly surprised.

More of a running full pelt, screaming, twirling my England shirt around my head type event :-)

Very pleasing update. It’s pretty obvious that non-COVID revenue is building and to communicated strategic plan. Lots of financial firepower still in the Bank.

Particularly like this part:

“The transition to non-COVID revenues in both Contract Manufacturing and Laboratory Services continues. The Company is bringing on new partners in the genomics and forensic space and successfully taking them through validation and pilot scale batches for products expected to be launched later in 2022 and into 2023. In addition, the Laboratory Services team recently launched a new clinical toxicology method geared toward medication adherence, developed an analysis of cannabis potency and has made major advances in establishing our capability in Non-Invasive Prenatal Testing ("NIPT"). The expansion of testing capabilities to create a broader suite of healthcare applications is proceeding well against the Company's roadmap, and it is reassuring to see early interest and new opportunities emerging as the team start to promote the new testing services.”

All systems GO at EKF.

Notice of AGM last year, was 1st Nov. AGM date 23rd Nov.

Could EKF be a global player in the Monkey Pox testing market I wonder?

Agree on the hairdressers point RW but think we could perm any number of possibilities around which RNS comes next.

C7 - take it easy pal.

2nd Gen needed…………

https://www.express.co.uk/life-style/health/1646408/ba-2-75-centaurus-covid-coronavirus-variant-of-concern-uk

Hi Violin re. Covidity “almost a year without any news on that front”

I get your point but there HAS been news updates by was of RNS in January and March of this year.

Thanks for feedback SB. Interesting.

Well, there goes July and void of news.

However, that also applied to May and was followed by 3x significant and positive RNS in June.

Not suggesting that is a deliberate pattern but would be highly surprised if we don’t see at least one significant RNS in August. Fingers crossed that to is of the very positive variety.

HAGW all.

Ivy -it was the “Boris parties” quip I was making.

Maybe I need another glass of vino tinto:-)

Had to chuckle at this line in Ivys 19:24.

“ just think it was a photo op for all parties”